Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.45
-0.0200-1.36%
Post-market: 1.450.00000.00%19:30 EST
Volume:37.07K
Turnover:53.64K
Market Cap:15.39M
PE:-0.87
High:1.48
Open:1.47
Low:1.41
Close:1.47
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:0.58
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6599
EPS(LYR):-2.8960
ROE:-317.47%
ROA:-86.45%
PB:5.86
PE(LYR):-0.50

Loading ...

Gold Falls Over 1%; Darden Posts Downbeat Earnings

Benzinga
·
Sep 19

BioCardia Announces $6 Million Public Offering

TIPRANKS
·
Sep 18

BioCardia Announces Pricing of up to $12 Million Public Offering

THOMSON REUTERS
·
Sep 18

Press Release: BioCardia Announces Pricing of Up To $12 Million Public Offering

Dow Jones
·
Sep 18

BioCardia announces CardiAMP Cell Therapy results

TIPRANKS
·
Sep 18

BioCardia: Cardiamp Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance

THOMSON REUTERS
·
Sep 18

BioCardia Inc - Reduced Angina Episodes at Six-Month Primary Follow-up

THOMSON REUTERS
·
Sep 18

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up

GlobeNewswire
·
Sep 18

BioCardia files to sell 2.8M shares of common stock, warrants

TIPRANKS
·
Sep 16

BioCardia Inc Files for Offering of up to 2.8 Mln Shares of Common Stock Together With up to 2.8 Mln Common Warrants

THOMSON REUTERS
·
Sep 16

BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025

GlobeNewswire
·
Sep 04

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Aug 25

BioCardia and CART-Tech Partner to Develop Heart3D™ Fusion Imaging for Cardiology

Reuters
·
Aug 13

BioCardia and Cart-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3d™ Fusion Imaging for Interventional Cardiology

THOMSON REUTERS
·
Aug 13

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Aug 12

BioCardia Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11

BioCardia Q2 EPS $(0.40) Beats $(0.50) Estimate

Benzinga
·
Aug 11

BioCardia Inc. Secures Patent for Innovative Catheter System Enhancing Heart Treatment Delivery

Reuters
·
Aug 11

BioCardia, Inc. Q2 Net Income USD -2.049 Million

THOMSON REUTERS
·
Aug 11

BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results

GlobeNewswire
·
Aug 11